ROADZEN INC (RDZN) Fundamental Analysis & Valuation

NASDAQ:RDZN • VGG7606H1082

Current stock price

1.07 USD
-0.08 (-6.96%)
At close:
1.0603 USD
-0.01 (-0.91%)
After Hours:

This RDZN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RDZN Profitability Analysis

1.1 Basic Checks

  • RDZN had negative earnings in the past year.
  • RDZN had a negative operating cash flow in the past year.
  • RDZN had negative earnings in 4 of the past 5 years.
  • RDZN had a negative operating cash flow in each of the past 5 years.
RDZN Yearly Net Income VS EBIT VS OCF VS FCFRDZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M

1.2 Ratios

  • RDZN has a Return On Assets of -34.32%. This is in the lower half of the industry: RDZN underperforms 78.91% of its industry peers.
Industry RankSector Rank
ROA -34.32%
ROE N/A
ROIC N/A
ROA(3y)-131.55%
ROA(5y)-78.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDZN Yearly ROA, ROE, ROICRDZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 500 -500 1K

1.3 Margins

  • RDZN's Gross Margin of 60.93% is on the low side compared to the rest of the industry. RDZN is outperformed by 60.73% of its industry peers.
  • RDZN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RDZN Yearly Profit, Operating, Gross MarginsRDZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

0

2. RDZN Health Analysis

2.1 Basic Checks

  • RDZN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • RDZN has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for RDZN is higher compared to a year ago.
RDZN Yearly Shares OutstandingRDZN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M
RDZN Yearly Total Debt VS Total AssetsRDZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • RDZN has an Altman-Z score of -7.27. This is a bad value and indicates that RDZN is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of RDZN (-7.27) is worse than 86.18% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.27
ROIC/WACCN/A
WACC10.92%
RDZN Yearly LT Debt VS Equity VS FCFRDZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.54 indicates that RDZN may have some problems paying its short term obligations.
  • RDZN has a worse Current ratio (0.54) than 91.27% of its industry peers.
  • RDZN has a Quick Ratio of 0.54. This is a bad value and indicates that RDZN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RDZN has a worse Quick ratio (0.54) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
RDZN Yearly Current Assets VS Current LiabilitesRDZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M

4

3. RDZN Growth Analysis

3.1 Past

  • RDZN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.62%, which is quite impressive.
  • Looking at the last year, RDZN shows a quite strong growth in Revenue. The Revenue has grown by 17.28% in the last year.
EPS 1Y (TTM)86.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)17.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.35% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, RDZN will show a very strong growth in Revenue. The Revenue will grow by 51.26% on average per year.
EPS Next Y83.35%
EPS Next 2Y39.39%
EPS Next 3Y28.35%
EPS Next 5YN/A
Revenue Next Year21.33%
Revenue Next 2Y35.56%
Revenue Next 3Y42.45%
Revenue Next 5Y51.26%

3.3 Evolution

RDZN Yearly Revenue VS EstimatesRDZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
RDZN Yearly EPS VS EstimatesRDZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

1

4. RDZN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RDZN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDZN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDZN Price Earnings VS Forward Price EarningsRDZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RDZN Per share dataRDZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

  • RDZN's earnings are expected to grow with 28.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.39%
EPS Next 3Y28.35%

0

5. RDZN Dividend Analysis

5.1 Amount

  • RDZN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

RDZN Fundamentals: All Metrics, Ratios and Statistics

ROADZEN INC

NASDAQ:RDZN (3/27/2026, 8:00:01 PM)

After market: 1.0603 -0.01 (-0.91%)

1.07

-0.08 (-6.96%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-12
Earnings (Next)N/A
Inst Owners11.29%
Inst Owner Change-16.94%
Ins Owners3.51%
Ins Owner Change0.11%
Market Cap85.28M
Revenue(TTM)50.30M
Net Income(TTM)-15.40M
Analysts82.5
Price Target5.1 (376.64%)
Short Float %0.42%
Short Ratio0.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-132.84%
Min EPS beat(2)-292.16%
Max EPS beat(2)26.47%
EPS beat(4)3
Avg EPS beat(4)-41.91%
Min EPS beat(4)-292.16%
Max EPS beat(4)96.08%
EPS beat(8)5
Avg EPS beat(8)-28.81%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.46%
Min Revenue beat(2)-12.63%
Max Revenue beat(2)11.72%
Revenue beat(4)1
Avg Revenue beat(4)-8.09%
Min Revenue beat(4)-24.8%
Max Revenue beat(4)11.72%
Revenue beat(8)1
Avg Revenue beat(8)-10.38%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-200%
EPS NQ rev (3m)-700%
EPS NY rev (1m)-52.17%
EPS NY rev (3m)-118.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.79%
Revenue NY rev (1m)-4.71%
Revenue NY rev (3m)-4.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.7
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.63
BVpS-0.33
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.32%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.93%
FCFM N/A
ROA(3y)-131.55%
ROA(5y)-78.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.65%
Cap/Sales 2.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -7.27
F-Score3
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)31.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y83.35%
EPS Next 2Y39.39%
EPS Next 3Y28.35%
EPS Next 5YN/A
Revenue 1Y (TTM)17.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.61%
Revenue Next Year21.33%
Revenue Next 2Y35.56%
Revenue Next 3Y42.45%
Revenue Next 5Y51.26%
EBIT growth 1Y87.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.24%
EBIT Next 3Y33.51%
EBIT Next 5YN/A
FCF growth 1Y-552.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-610.62%
OCF growth 3YN/A
OCF growth 5YN/A

ROADZEN INC / RDZN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ROADZEN INC?

ChartMill assigns a fundamental rating of 1 / 10 to RDZN.


What is the valuation status for RDZN stock?

ChartMill assigns a valuation rating of 1 / 10 to ROADZEN INC (RDZN). This can be considered as Overvalued.


How profitable is ROADZEN INC (RDZN) stock?

ROADZEN INC (RDZN) has a profitability rating of 0 / 10.


What is the expected EPS growth for ROADZEN INC (RDZN) stock?

The Earnings per Share (EPS) of ROADZEN INC (RDZN) is expected to grow by 83.35% in the next year.